Daniel Sklansky, MD


  1. Describe outcome trends for NH
  2. Identify supplemental NH risk stratification tools
  3. Characterize risks associated with NH
  4. Explain novel NH treatment options
  5. Apply knowledge of risks, benefits, and patient characteristics to clinical management of NH
Session date: 
11/14/2019 - 7:30am to 8:30am CST
Health Sciences Learning Center
750 Highland Avenue
Room 1345
Madison, WI 53792
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report
Daniel Sklansky, MD